ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Centers See Trend To Integrate Control Service With Science

February 18, 1983

In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director

January 27, 1978

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

Panel Explores Barriers In Access To Cancer Care.

February 2, 2001

ACS Encourages Grant Applications In All Aspects Of Pain Control

May 7, 1993

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998